CE - Celanese Corporation

$53.13 0.14 (-0.26%) Last updated: May 31, 2026 02:48

52-Week Range

$53.13

$35.13 $53.13 $70.70

Fundamentals Overview

Celanese Corporation is in the middle of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/B 1.43 P/S 0.61

Intrinsic value (DCF)

+233.9% upside vs price

Risk (Beta)

0.81 — in line vol

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Buy — 66% confidence Risk: Moderate Volatility — Beta 0.81. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +233.9% upside vs price · Sentiment improving (2 upgrades) · 3M vs Basic Materials sector: +9.8%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$5.83B

P/E (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

0.23%

52-Week Range

$35.13 - $70.70

Volume vs Avg

N/A

Beta

0.81

About

Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through three segments: Engineered Materials, Acetate Tow, and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics. It also offers acesulfame potassium, a...

Sector: Basic Materials

Headquarters: US

Employees: 11,000

IPO Date: Jan 2005

Website: www.celanese.com

Beta: 0.81 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: C. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 7, Equal Weight: 3, In Line: 2, Neutral: 10, Outperform: 1, Overweight: 4, Sector Perform: 3.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $177.41; current price is $53.13. That’s a +233.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	N/A
DCF value (model)	$177.41 (233.9% upside)
PEG (TTM)	N/A
P/B (TTM)	1.43
P/S (TTM)	0.61
P/FCF (TTM)	6.17
Liquidity & enterprise
Current Ratio (TTM)	1.38
Quick Ratio (TTM)	0.85
Cash Ratio (TTM)	0.41
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	-11.54%
Gross margin (TTM)	19.83%
Operating margin (TTM)	-7.64%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CE.

Analyst Sentiment at a Glance

C Sentiment Improving

Buy 7Equal Weight 3In Line 2Neutral 10Outperform 1Overweight 4Sector Perform 3

2 upgrades, 1 downgrade

Price Target Consensus

Current $53.13

Median $63.50

Consensus $65.60

Low consensus $50.00

High consensus $86.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
JP Morgan	upgrade	Neutral	Overweight	2026-05-12
RBC Capital	maintain	Sector Perform	Sector Perform	2026-05-11
Wells Fargo	maintain	Overweight	Overweight	2026-05-08
JP Morgan	maintain	Neutral	Neutral	2026-05-07
Citigroup	maintain	Buy	Buy	2026-05-07
Mizuho	maintain	Neutral	Neutral	2026-05-06
Morgan Stanley	maintain	Equal Weight	Equal Weight	2026-05-05
B of A Securities	maintain	Buy	Buy	2026-04-21
Citigroup	maintain	Buy	Buy	2026-04-16
Wells Fargo	maintain	Overweight	Overweight	2026-04-10
UBS	maintain	Neutral	Neutral	2026-04-09
Mizuho	maintain	Neutral	Neutral	2026-03-31
Baird	maintain	Outperform	Outperform	2026-03-27
UBS	maintain	Neutral	Neutral	2026-03-18
Wells Fargo	upgrade	Equal Weight	Overweight	2026-03-13
Citigroup	maintain	Buy	Buy	2026-03-12
RBC Capital	maintain	Sector Perform	Sector Perform	2026-02-23
JP Morgan	maintain	Neutral	Neutral	2026-02-19
Citigroup	maintain	Buy	Buy	2026-02-19
Wells Fargo	maintain	Equal Weight	Equal Weight	2026-02-19
UBS	maintain	Neutral	Neutral	2026-02-19
Evercore ISI Group	maintain	In Line	In Line	2026-02-18
Mizuho	maintain	Neutral	Neutral	2026-02-18
RBC Capital	maintain	Sector Perform	Sector Perform	2026-01-16
Citigroup	maintain	Buy	Buy	2026-01-15
UBS	maintain	Neutral	Neutral	2026-01-12
Wells Fargo	downgrade	Overweight	Equal Weight	2025-12-19
Citigroup	maintain	Buy	Buy	2025-12-18
UBS	maintain	Neutral	Neutral	2025-11-12
Evercore ISI Group	maintain	In Line	In Line	2025-11-11